Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07769190 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07769190 · ClinicalTrials.gov record · last posted 2026-08-17

Cardiovascular Mortality Prediction in Maintenance Hemodialysis Patients

StatusCompleted
PhaseNot specified
Started2021-07-16
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This prospective, single-center observational cohort study evaluates cardiovascular mortality risk in adults receiving maintenance hemodialysis. During the first year after enrollment, four scheduled assessments are used to characterize demographic factors, dialysis treatment, medication use, routine laboratory measures, and the proportion of serum phosphate measurements within the protocol-defined target range. Participants are subsequently followed for cardiovascular mortality. The study evaluates factors associated with serum phosphate target achievement and develops a cardiovascular mortality prediction model in the overall cohort, with a prespecified subgroup analysis among participants who undergo parathyroidectomy. No treatment or procedure is assigned by the study investigators.
Trial Details
NCT Number NCT07769190
Lead Sponsor Huashan Hospital
Conditions End-Stage Kidney Disease (ESKD), Cardiovascular Disease, Secondary Hyperparathyroidism (SHPT)
Enrollment 192 participants
Start Date 2021-07-16
Primary Completion 2022-04-21 (estimated)
Study Completion 2022-04-21 (estimated)
Updated on ClinicalTrials.gov 2026-08-17